Table of Contents Author Guidelines Submit a Manuscript
International Journal of Endocrinology
Volume 2014, Article ID 959781, 8 pages
http://dx.doi.org/10.1155/2014/959781
Research Article

Free Triiodothyronine Concentrations Are Inversely Associated with Microalbuminuria

1Shanghai Clinical Center for Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Department of Endocrinology and Metabolism, Rui-Jin Hospital, Shanghai Jiao-Tong University School of Medicine, 197 Rui-Jin 2nd Road, Shanghai 200025, China
2Key Laboratory for Endocrine and Metabolic Diseases of Ministry of Health, Rui-Jin Hospital, Shanghai Jiao-Tong University School of Medicine, E-Institute of Shanghai Universities, Shanghai 200025, China

Received 29 June 2014; Revised 27 October 2014; Accepted 28 October 2014; Published 16 November 2014

Academic Editor: Giorgio Iervasi

Copyright © 2014 Yulin Zhou et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. C. Viberti, R. J. Jarrett, R. D. Hill, A. Argyropoulos, U. Mahmud, and H. Keen, “Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus,” The Lancet, vol. 1, no. 8287, pp. 1430–1432, 1982. View at Publisher · View at Google Scholar · View at Scopus
  2. H. C. Gerstein, J. F. E. Mann, J. Pogue et al., “Prevalence and determinants of microalbuminuria in high-risk diabetic and nondiabetic patients in the heart outcomes prevention evaluation study,” Diabetes Care, vol. 23, no. 2, pp. B35–B39, 2000. View at Google Scholar · View at Scopus
  3. S. Romundstad, J. Holmen, H. Hallan, K. Kvenild, and H. Ellekjær, “Microalbuminuria and all-cause mortality in treated hypertensive individuals: does sex matter? The Nord-Trøndelag Health Study (HUNT), Norway,” Circulation, vol. 108, no. 22, pp. 2783–2789, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. G. F. M. Strippoli, M. Craig, J. J. Deeks, F. P. Schena, and J. C. Craig, “Effects of angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists on mortality and renal outcomes in diabetic nephropathy: systematic review,” British Medical Journal, vol. 329, no. 7470, pp. 828–831, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. J.-M. Halimi, S. Hadjadj, V. Aboyans et al., “Microalbuminuria and urinary albumin excretion: French clinical practice guidelines,” Diabetes & Metabolism, vol. 33, no. 4, pp. 303–309, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. G. Pasqualetti, S. Tognini, A. Polini, N. Caraccio, and F. Monzani, “Is subclinical hypothyroidism a cardiovascular risk factor in the elderly?” Journal of Clinical Endocrinology and Metabolism, vol. 98, no. 6, pp. 2256–2266, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Taddei, N. Caraccio, A. Virdis et al., “Impaired endothelium-dependent vasodilatation in subclinical hypothyroidism: beneficial effect of levothyroxine therapy,” Journal of Clinical Endocrinology and Metabolism, vol. 88, no. 8, pp. 3731–3737, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. K. Fukuyama, T. Ichiki, K. Takeda et al., “Downregulation of vascular angiotensin II type 1 receptor by thyroid hormone,” Hypertension, vol. 41, no. 3, pp. 598–603, 2003. View at Publisher · View at Google Scholar · View at Scopus
  9. B. Biondi, “Cardiovascular effects of mild hypothyroidism,” Thyroid, vol. 17, no. 7, pp. 625–630, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Singh and S. C. Satchell, “Microalbuminuria: causes and implications,” Pediatric Nephrology, vol. 26, no. 11, pp. 1957–1965, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. M. M. El-Eshmawy, H. A. Abd El-Hafez, W. O. El Shabrawy, and I. A. Abdel Aal, “Subclinical hypothyroidism is independently associated with microalbuminuria in a cohort of prediabetic Egyptian adults,” Diabetes and Metabolism Journal, vol. 37, no. 6, pp. 450–457, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. T. Wang, M. Li, B. Chen et al., “Urinary bisphenol A (BPA) concentration associates with obesity and insulin resistance,” Journal of Clinical Endocrinology and Metabolism, vol. 97, no. 2, pp. e223–e227, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults, “Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III),” The Journal of the American Medical Association, vol. 285, no. 19, pp. 2486–2497, 2001. View at Publisher · View at Google Scholar · View at Scopus
  14. Y.-C. Ma, L. Zuo, J.-H. Chen et al., “Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease,” Journal of the American Society of Nephrology, vol. 17, no. 10, pp. 2937–2944, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Li, M. Xu, Y. Bi et al., “Association between higher serum fetuin—a concentrations and abnormal albuminuria in middle-aged and elderly Chinese with normal glucose tolerance,” Diabetes Care, vol. 33, no. 11, pp. 2462–2464, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. T. Wang, J. Lu, M. Xu et al., “Urinary bisphenol a concentration and thyroid function in Chinese adults,” Epidemiology, vol. 24, no. 2, pp. 295–302, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. C. A. Jones, M. E. Francis, M. S. Eberhardt et al., “Microalbuminuria in the US population: third National Health and Nutrition Examination Survey,” American Journal of Kidney Diseases, vol. 39, no. 3, pp. 445–459, 2002. View at Publisher · View at Google Scholar · View at Scopus
  18. R. Pedrinelli, G. Dell'Omo, G. Penno, and M. Mariani, “Non-diabetic microalbuminuria, endothelial dysfunction and cardiovascular disease,” Vascular Medicine, vol. 6, no. 4, pp. 257–264, 2001. View at Publisher · View at Google Scholar · View at Scopus
  19. N. Rodondi, W. P. J. den Elzen, D. C. Bauer et al., “Subclinical hypothyroidism and the risk of coronary heart disease and mortality,” The Journal of the American Medical Association, vol. 304, no. 12, pp. 1365–1374, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. B. Biondi and D. S. Cooper, “The clinical significance of subclinical thyroid dysfunction,” Endocrine Reviews, vol. 29, no. 1, pp. 76–131, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. E. Tatar, F. Kircelli, G. Asci et al., “Associations of triiodothyronine levels with carotid atherosclerosis and arterial stiffness in hemodialysis patients,” Clinical Journal of the American Society of Nephrology, vol. 6, no. 9, pp. 2240–2246, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. D. H. Endemann and E. L. Schiffrin, “Endothelial dysfunction,” Journal of the American Society of Nephrology, vol. 15, no. 8, pp. 1983–1992, 2004. View at Publisher · View at Google Scholar · View at Scopus
  23. M. I. Yilmaz, A. Sonmez, M. Karaman et al., “Low triiodothyronine alters flow-mediated vasodilatation in advanced nondiabetic kidney disease,” American Journal of Nephrology, vol. 33, no. 1, pp. 25–32, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. B. Biondi, M. Galderisi, L. Pagano et al., “Endothelial-mediated coronary flow reserve in patients with mild thyroid hormone deficiency,” European Journal of Endocrinology, vol. 161, no. 2, pp. 323–329, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. K. Fukuyama, T. Ichiki, I. Imayama et al., “Thyroid hormone inhibits vascular remodeling through suppression of cAMP response element binding protein activity,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 26, no. 9, pp. 2049–2055, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. S. Taddei and A. Salvetti, “Endothelial dysfunction in essential hypertension: clinical implications,” Journal of Hypertension, vol. 20, no. 9, pp. 1671–1674, 2002. View at Publisher · View at Google Scholar · View at Scopus
  27. P. Ruggenenti and G. Remuzzi, “Time to abandon microalbuminuria?” Kidney International, vol. 70, no. 7, pp. 1214–1222, 2006. View at Publisher · View at Google Scholar · View at Scopus
  28. L. Palaniappan, M. Carnethon, and S. P. Fortmann, “Association between microalbuminuria and the metabolic syndrome: NHANES III,” American Journal of Hypertension, vol. 16, no. 11, pp. 952–958, 2003. View at Publisher · View at Google Scholar · View at Scopus
  29. R. H. Eckel, S. M. Grundy, and P. Z. Zimmet, “The metabolic syndrome,” The Lancet, vol. 365, no. 9468, pp. 1415–1428, 2005. View at Publisher · View at Google Scholar · View at Scopus
  30. J. D. J. Garduño-Garcia, U. Alvirde-Garcia, G. López-Carrasco et al., “TSH and free thyroxine concentrations are associated with differing metabolic markers in euthyroid subjects,” European Journal of Endocrinology, vol. 163, no. 2, pp. 273–278, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. S. de Cosmo, A. Minenna, O. Ludovico et al., “Increased urinary albumin excretion, insulin resistance, and related cardiovascular risk factors in patients with type 2 diabetes: evidence of a sex-specific association,” Diabetes Care, vol. 28, no. 4, pp. 910–915, 2005. View at Publisher · View at Google Scholar · View at Scopus
  32. R. Pedrinelli, O. Giampietro, F. Carmassi et al., “Microalbuminuria and endothelial dysfunction in essential hypertension,” The Lancet, vol. 344, no. 8914, pp. 14–18, 1994. View at Publisher · View at Google Scholar · View at Scopus
  33. G.-D. Xiang, Y.-S. He, L.-S. Zhao, J. Hou, L. Yue, and H.-J. Xiang, “Impairment of endothelium-dependent arterial dilation in Hashimoto's thyroiditis patients with euthyroidism,” Clinical Endocrinology, vol. 64, no. 6, pp. 698–702, 2006. View at Publisher · View at Google Scholar · View at Scopus
  34. L. Jiang, W. Huang, Y. Liang et al., “Metabolic syndrome, C-reactive protein and microalbuminuria in a rural Chinese population: a cross-sectional study,” BMC Nephrology, vol. 14, no. 1, article 118, 2013. View at Publisher · View at Google Scholar · View at Scopus
  35. G. Eknoyan, T. Hostetter, G. L. Bakris et al., “Proteinuria and other markers of chronic kidney disease: a position statement of the National Kidney Foundation (NKF) and the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),” American Journal of Kidney Diseases, vol. 42, no. 4, pp. 617–622, 2003. View at Publisher · View at Google Scholar · View at Scopus